These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 18708992

  • 21. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
    Nashan B, Saliba F, Durand F, Barcéna R, Herrero JI, Mentha G, Neuhaus P, Bowles M, Patch D, Bernardos A, Klempnauer J, Bouw R, Ives J, Mamelok R, McKay D, Truman M, Marotta P.
    Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
    [Abstract] [Full Text] [Related]

  • 22. Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease.
    de Winter BC, Mathot RA, Sombogaard F, Neumann I, van Hest RM, Doorduijn JK, van Gelder T.
    Ther Drug Monit; 2010 Oct; 32(5):606-14. PubMed ID: 20720518
    [Abstract] [Full Text] [Related]

  • 23. Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: effect of cyclosporine and tacrolimus comedication.
    Brown NW, Aw MM, Mieli-Vergani G, Dhawan A, Tredger JM.
    Ther Drug Monit; 2002 Oct; 24(5):598-606. PubMed ID: 12352931
    [Abstract] [Full Text] [Related]

  • 24. Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients.
    Gregoor PJ, de Sévaux RG, Hené RJ, Hesse CJ, Hilbrands LB, Vos P, van Gelder T, Hoitsma AJ, Weimar W.
    Transplantation; 1999 Nov 27; 68(10):1603-6. PubMed ID: 10589962
    [Abstract] [Full Text] [Related]

  • 25. The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.
    Grinyó JM, Ekberg H, Mamelok RD, Oppenheimer F, Sánchez-Plumed J, Gentil MA, Hernandez D, Kuypers DR, Brunet M.
    Nephrol Dial Transplant; 2009 Jul 27; 24(7):2269-76. PubMed ID: 19357111
    [Abstract] [Full Text] [Related]

  • 26. Mycophenolate mofetil pharmacokinetic monitoring in pediatric kidney transplant recipients.
    Ghio L, Ferraresso M, Viganò SM, Ginevri F, Perfumo F, Gianoglio B, Murer L, Zacchello G, Dello Strologo L, Cardillo M, Tirelli S, Valente U, Edefonti A.
    Transplant Proc; 2005 Mar 27; 37(2):856-8. PubMed ID: 15848555
    [Abstract] [Full Text] [Related]

  • 27. Nonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: implications for therapeutic drug monitoring.
    de Winter BC, Mathot RA, Sombogaard F, Vulto AG, van Gelder T.
    Clin J Am Soc Nephrol; 2011 Mar 27; 6(3):656-63. PubMed ID: 21088289
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH.
    Ther Drug Monit; 2008 Jun 27; 30(3):282-91. PubMed ID: 18520599
    [Abstract] [Full Text] [Related]

  • 29. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V, Tchervenkov J, Metrakos P, Barkun J, Deschenes M, Cantarovich M.
    Clin Ther; 2005 Apr 27; 27(4):463-9. PubMed ID: 15922819
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients.
    Colom H, Lloberas N, Andreu F, Caldés A, Torras J, Oppenheimer F, Sanchez-Plumed J, Gentil MA, Kuypers DR, Brunet M, Ekberg H, Grinyó JM.
    Kidney Int; 2014 Jun 27; 85(6):1434-43. PubMed ID: 24402086
    [Abstract] [Full Text] [Related]

  • 31. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T, Luszczynska P, Durlik M, Majchrzak J, Baczkowska T, Chrzanowska M, Sobiak J, Glyda M, Kuriata-Kordek M, Kamińska D, Krajewska M, Klinger M.
    Ther Drug Monit; 2013 Dec 27; 35(6):760-9. PubMed ID: 24192641
    [Abstract] [Full Text] [Related]

  • 32. Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study.
    Noreikaitė A, Saint-Marcoux F, Marquet P, Kaduševičius E, Stankevičius E.
    Medicine (Baltimore); 2017 Mar 27; 96(13):e6469. PubMed ID: 28353583
    [Abstract] [Full Text] [Related]

  • 33. Long-term pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients over 3 years posttransplant.
    Weber LT, Hoecker B, Armstrong VW, Oellerich M, Tönshoff B.
    Ther Drug Monit; 2008 Oct 27; 30(5):570-5. PubMed ID: 18758392
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
    Lobritto SJ, Rosenthal P, Bouw R, Leung M, Snell P, Mamelok RD.
    Liver Transpl; 2007 Nov 27; 13(11):1570-5. PubMed ID: 17969194
    [Abstract] [Full Text] [Related]

  • 35. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
    Staatz CE, Tett SE.
    Clin Pharmacokinet; 2007 Nov 27; 46(1):13-58. PubMed ID: 17201457
    [Abstract] [Full Text] [Related]

  • 36. Atypical pharmacokinetics and metabolism of mycophenolic acid in a young kidney transplant recipient with impaired renal function.
    Wigger M, Armstrong VW, Shipkova M, Wacke R, Nizze H, Streit F, von Ahsen N, Muscheites J, Glasenapp S, Stolpe HJ, Oellerich M.
    Ther Drug Monit; 2002 Jun 27; 24(3):438-43. PubMed ID: 12021639
    [Abstract] [Full Text] [Related]

  • 37. Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients?
    Meiser BM, Groetzner J, Kaczmarek I, Landwehr P, Müller M, Jung S, Uberfuhr P, Fraunberger P, Stempfle HU, Weis M, Reichart B.
    Transplantation; 2004 Aug 27; 78(4):591-8. PubMed ID: 15446320
    [Abstract] [Full Text] [Related]

  • 38. Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil.
    Kuypers DR, Vanrenterghem Y, Squifflet JP, Mourad M, Abramowicz D, Oellerich M, Armstrong V, Shipkova M, Daems J.
    Ther Drug Monit; 2003 Oct 27; 25(5):609-22. PubMed ID: 14508385
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor-Free Renal Transplant Recipients.
    Graff J, Scheuermann EH, Brandhorst G, Oellerich M, Gossmann J.
    Ther Drug Monit; 2016 Jun 27; 38(3):388-92. PubMed ID: 26829599
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetic evaluation of MFF in combinations with tacrolimus and cyclosporine. Findings of C0 and AUC.
    Radzevičienė A, Stankevičius E, Saint-Marcoux F, Marquet P, Maslauskienë R, Kaduševičius E.
    Medicine (Baltimore); 2020 Mar 27; 99(12):e19441. PubMed ID: 32195940
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.